“The lay person sees them pr’ing their 13-d group and the stock has declined to sub $2.”
The 13d has not PR’d anything. There were two 8ks released, which are mandatory. And the stock went below $2 as a result of the FDA letter and continued HIV BLA delays, not the 13d 8k.